Hepatocyte transplantation improves survival in mice with liver toxicity induced by hepatic overexpression of Mad1 transcription factor

被引:23
作者
Gagandeep, S
Sokhi, R
Slehria, S
Gorla, GR
Furgiuele, J
DePinho, RA
Gupta, S
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Comprehens Canc Res Ctr, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10461 USA
[5] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[6] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
acute liver failure; cell cycle; dipeptidyl peptidase IV; hepatocyte transplantation; liver; Mad; mouse;
D O I
10.1006/mthe.2000.0051
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hepatic overexpression of Mad1 with an adenoviral vector, AdMad, induced liver toxicity in immunodeficient mice. Transduction of cultured hepatocytes with AdMad inhibited cellular DNA synthesis and cell cycling, along with increased lactate dehydrogenase release, indicating cytotoxicity. When dipeptidyl peptidase IV-deficient F344 rat hepatocytes were transplanted into the liver of immunodeficient mice after treatment with AdMad, significant portions of the liver were repopulated. This was in agreement with corresponding losses of host hepatocytes, which showed increased apoptosis rates. Mortality in mice following AdMad treatment decreased significantly when animals were subjected to hepatocyte transplantation. The findings indicated that Mad1 overexpression perturbed hepatocyte survival. Investigation of pathophysiological mechanisms concerning specific cell cycle regulators in acute liver toxicity will thus be appropriate. Cell therapy has potential for treating acute liver injury under suitable circumstances.
引用
收藏
页码:358 / 365
页数:8
相关论文
共 32 条
[1]   EFFECTS OF INTRASPLENIC INJECTION OF HEPATOCYTES, HEPATOCYTE FRAGMENTS AND HEPATOCYTE CULTURE SUPERNATANTS ON D-GALACTOSAMINE-INDUCED LIVER-FAILURE IN RATS [J].
BAUMGARTNER, D ;
LAPLANTEONEILL, PM ;
SUTHERLAND, DER ;
NAJARIAN, JS .
EUROPEAN SURGICAL RESEARCH, 1983, 15 (03) :129-135
[2]   Control of cell proliferation by Myc [J].
Bouchard, C ;
Staller, P ;
Eilers, M .
TRENDS IN CELL BIOLOGY, 1998, 8 (05) :202-206
[3]  
CHAMULEAU RAF, 1997, HEPATOCYTE TRANSPLAN, P159
[4]   EFFECTS OF THE MYC ONCOGENE ANTAGONIST, MAD, ON PROLIFERATION, CELL CYCLING AND THE MALIGNANT PHENOTYPE OF HUMAN BRAIN-TUMOR CELLS [J].
CHEN, J ;
WILLINGHAM, T ;
MARGRAF, LR ;
SCHREIBERAGUS, N ;
DEPINHO, RA ;
NISEN, PD .
NATURE MEDICINE, 1995, 1 (07) :638-643
[5]   CONTRASTING ROLES FOR MYC AND MAD PROTEINS IN CELLULAR GROWTH AND DIFFERENTIATION [J].
CHIN, L ;
SCHREIBERAGUS, N ;
PELLICER, I ;
CHEN, K ;
LEE, HW ;
DUDAST, M ;
CORDONCARDO, C ;
DEPINHO, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8488-8492
[6]   Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation [J].
Foley, KP ;
McArthur, GA ;
Quéva, C ;
Hurlin, PJ ;
Soriano, P ;
Eisenman, RN .
EMBO JOURNAL, 1998, 17 (03) :774-785
[7]   Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines [J].
Gagandeep, S ;
Novikoff, PM ;
Ott, M ;
Gupta, S .
CANCER LETTERS, 1999, 136 (01) :109-118
[8]   Rapid clearance of syngeneic transplanted hepatocytes following transduction with E-1-deleted adenovirus indicates early host immune responses and offers novel ways for studying viral vector, target cell and host interactions [J].
Gagandeep, S ;
Ott, M ;
Sokhi, RP ;
Gupta, S .
GENE THERAPY, 1999, 6 (05) :729-736
[9]  
GAGANDEEP S, 2000, IN PRESS J GENE MED
[10]  
Gupta S, 2000, J PATHOL, V190, P203